Skip to main content
. 2013 Oct 31;8(10):e77849. doi: 10.1371/journal.pone.0077849

Figure 4. Other adverse effects of patients treated with Endovascular Therapy and Intravenous Thrombolysis after acute ischemic stroke.

Figure 4

(A) Forest plot of RR and 95% CI for the occurrence of Neurologic deterioration at Day 7 in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (B) Forest plot of RR and 95% CI for the occurrence of recurrent ischemic stroke in patients assigned to Endovascular Therapy and Intravenous Thrombolysis. (C) Forest plot of RR and 95% CI for the occurrence of cerebral edema in patients assigned to Endovascular Therapy and Intravenous Thrombolysis.